Education
About Us
Working with TipRanks
Follow Us
Moderna (MRNA)
NASDAQ:MRNA
Total Valuation
Moderna has a market cap or net worth of $10.50B. The enterprise value is $9.73B.
Market Cap$10.50B
Enterprise Value$9.73B
Share Statistics
Moderna has 385,815,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding385,815,900
Owned by Insiders18.59%
Owned by Institutions0.47%
Financial Efficiency
Moderna’s return on equity (ROE) is -0.33 and return on invested capital (ROIC) is -32.63%.
Return on Equity (ROE)-0.33
Return on Assets (ROA)-0.25
Return on Invested Capital (ROIC)-32.63%
Return on Capital Employed (ROCE)-0.33
Revenue Per Employee557.93K
Profits Per Employee-613.97K
Employee Count5,800
Asset Turnover0.23
Inventory Turnover12.51
Valuation Ratios
The current PE Ratio of Moderna is -4.48. Moderna’s PEG ratio is 0.18.
PE Ratio-4.48
PS Ratio3.89
PB Ratio1.46
Price to Fair Value1.46
Price to FCF-3.94
Price to Operating Cash Flow-5.32
PEG Ratio0.18
Income Statement
In the last 12 months, Moderna had revenue of 3.24B and earned -3.56B in profits. Earnings per share was -9.27.
Revenue3.24B
Gross Profit1.77B
Operating Income-3.94B
Pretax Income-3.61B
Net Income-3.56B
EBITDA-3.39B
Earnings Per Share (EPS)-9.27
Cash Flow
In the last 12 months, operating cash flow was -3.00B and capital expenditures -1.05B, giving a free cash flow of -4.05B billion.
Operating Cash Flow-3.00B
Free Cash Flow-4.05B
Free Cash Flow per Share-10.51
Dividends & Yields
Moderna pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.27
52-Week Price Change-75.61%
50-Day Moving Average30.69
200-Day Moving Average54.16
Relative Strength Index (RSI)47.00
Average Volume (3m)9.03M
Important Dates
Moderna upcoming earnings date is May 1, 2025, TBA Not Confirmed.
Last Earnings DateFeb 14, 2025
Next Earnings DateMay 1, 2025
Ex-Dividend Date―
Financial Position
Moderna as a current ratio of 3.67, with Debt / Equity ratio of 6.51%
Current Ratio3.67
Quick Ratio3.62
Debt to Market Cap0.04
Net Debt to EBITDA0.36
Interest Coverage Ratio-164.38
Taxes
In the past 12 months, Moderna has paid -46.00M in taxes.
Income Tax-46.00M
Effective Tax Rate0.01
Enterprise Valuation
Moderna EV to EBITDA ratio is -4.35, with an EV/FCF ratio of -3.64.
EV to Sales4.56
EV to EBITDA-4.35
EV to Free Cash Flow-3.64
EV to Operating Cash Flow-4.91
Balance Sheet
Moderna has $1.93B in cash and marketable securities with $0.00 in debt, giving a net cash position of -$1.22B billion.
Cash & Marketable Securities$1.93B
Total Debt$0.00
Net Cash-$1.22B
Net Cash Per Share-$3.15
Tangible Book Value Per Share$28.15
Margins
Gross margin is 52.28%, with operating margin of -121.91%, and net profit margin of -110.04%.
Gross Margin52.28%
Operating Margin-121.91%
Pretax Margin-111.46%
Net Profit Margin-110.04%
EBITDA Margin-104.88%
EBIT Margin-110.72%
Analyst Forecast
The average price target for Moderna is $46.88, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$46.88
Price Target Upside72.23% Upside
Analyst ConsensusHold
Analyst Count18
Revenue Growth Forecast-52.75%
EPS Growth Forecast25.00%